GRAUERSTAR h25
Conditions
Interventions
Group 1: The patient will receive the study lens (model 1R211R) into one eye and the control lens (TECNIS® One-Piece monofocal IOL) into the other eye. This process is randomized.
Group 2: Patient wil
Sponsors
AMO Germany
Vertretung für Europa
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Healthy patients with bilateral cataract; women must not be pregnant or breast-feeding
Exclusion criteria
Exclusion criteria: uncontrolled systemic or oculare deseases; participation in another study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The visual acuity of patients will be determined in different distances one and three months after implantation of the IOLs. A questionnaire on the satisfaction of the patients will be filled in. | — |
Secondary
| Measure | Time frame |
|---|---|
| Advers events according ISO 14155 will be evaluated during the course of the study. During the postoperative examinations after 1 and 3 months, optical-visual symptoms, lens related and medical complications will be evaluated. A questionnaire for the subjective satisfaction of the patients will be performed. | — |
Countries
Austria, Germany
Contacts
Public ContactRoland Pohl
AMO Vertreter für Europa
Outcome results
None listed